Cocrystal Pharma Announces Filing 2017 Second Quarter Financial Statements and Provides Company Update
ATLANTA, GA and BOTHELL, WA--(Marketwired - Aug 8, 2017) - Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for human diseases, today announced the filing of its financial statements for the quarter ending …